YL, E., S, D., AB, P., CD, S., & K, Z. (2024). Treatment of pancreatic adenocarcinoma in relation to survival in the U.S. Military Health System. Cancer epidemiology, 88, 102520. https://doi.org/10.1016/j.canep.2023.102520
Chicago Style (17th ed.) CitationYL, Eaglehouse, Darmon S, Park AB, Shriver CD, and Zhu K. "Treatment of Pancreatic Adenocarcinoma in Relation to Survival in the U.S. Military Health System." Cancer Epidemiology 88 (2024): 102520. https://doi.org/10.1016/j.canep.2023.102520.
MLA (9th ed.) CitationYL, Eaglehouse, et al. "Treatment of Pancreatic Adenocarcinoma in Relation to Survival in the U.S. Military Health System." Cancer Epidemiology, vol. 88, 2024, p. 102520, https://doi.org/10.1016/j.canep.2023.102520.
Warning: These citations may not always be 100% accurate.